Johnson & Johnson Innovation – JJDC co-led the computational pathology technology provider's series C round to take its total funding to $195m.

Atalanta Therapeutics has launched out of UMass with $110m in combined series A and partnership funding to develop therapies for neurodegenerative diseases.

SoftBank paid $350m for a 30% stake in the satellite internet system developer, which has emerged from bankruptcy, while Hughes Network Systems supplied the other $50m.

Kaiser Foundation Hospitals and Medpace took part in a round that will support phase 3 trials for the startup's lead cardiometabolic disease drug candidate.

Existing investor Scania co-led a series D round in which the trucking services platform developer achieved a valuation above $1bn.

Illumina Ventures and AV8 Ventures returned for a series A round that will push the startup's liquid biopsy technology towards the clinical trial stage.

Lundbeck and Novo were among the participants in the immuno-oncology drug developer's series B round having backed its series A four years ago.

The driverless vehicle technology developer has added $110m to the $200m supplied by busmaker Yutong Group last month.

The Salesforce-backed lending software provider roughly doubled its valuation to $3.3bn in just five months, Coatue and Tiger Global Management co-leading its latest round.

The Stripe-backed cross-border payment platform developer more than doubled its valuation to $2.5bn in the Coatue-led round.